Literature DB >> 17119006

Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development.

Juha Martola1, Leszek Stawiarz, Sten Fredrikson, Jan Hillert, Jakob Bergström, Olof Flodmark, Maria Kristoffersen Wiberg.   

Abstract

BACKGROUND: In multiple sclerosis (MS), multiple periventricular lesions are commonly the first findings on MRI. However, most of these MS lesions are clinically silent. The brain atrophy rate has shown better correlation to physical disability, but it is not clear how atrophy develops over decades. Corpus callosum forms the roof of the third and lateral ventricles. The corpus callosum area (CCA) in a midsagittal image is age independent in a normal adult population up to the seventh decade; therefore it can be used as a marker for non-age-related, pathological brain atrophy.
OBJECTIVES: To investigate whether and how CCA decreases in size over time in patients with MS.
METHODS: In a clinical observational study, 37 patients with MS with a wide range of disease duration at baseline (1-33 years) were followed. Three different MS courses were represented. The mean of individual MRI follow-up was 9 years. Multiple sclerosis severity score (MSSS) was also applied to evaluate disability at baseline and after 9 years of follow-up.
RESULTS: A significant decrease in CCA over 9 years (p<0.001) and a persisting association between CCA and the disability status were found. The atrophy rate was similar ever four decades of MS for all MS courses. The mean annual CCA decrease was 9.25 mm2 (1.8%). Surprisingly, atrophy rate did not correlate with sex, disease duration, age at MS onset or MS course.
CONCLUSIONS: Serial evaluations of CCA might be a robust method in monitoring a non-age-related decrease in CCA, reflecting progression of irreversible destructive changes in MS.

Entities:  

Mesh:

Year:  2006        PMID: 17119006      PMCID: PMC2077793          DOI: 10.1136/jnnp.2006.106690

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  37 in total

1.  Correlations of brain MRI parameters to disability in multiple sclerosis.

Authors:  K Schreiber; P S Sørensen; N Koch-Henriksen; A Wagner; M Blinkenberg; C Svarer; H C Petersen
Journal:  Acta Neurol Scand       Date:  2001-07       Impact factor: 3.209

2.  Sex differences in corpus callosum size: relationship to age and intracranial size.

Authors:  E V Sullivan; M J Rosenbloom; J E Desmond; A Pfefferbaum
Journal:  Neurobiol Aging       Date:  2001 Jul-Aug       Impact factor: 4.673

3.  Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications.

Authors:  M Rovaris; G Comi; M A Rocca; J S Wolinsky; M Filippi
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

4.  Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

Authors:  Y Ge; R I Grossman; J K Udupa; L Wei; L J Mannon; M Polansky; D L Kolson
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

5.  Ventricular enlargement in multiple sclerosis: a comparison of three-dimensional and linear MRI estimates.

Authors:  B Turner; N Ramli; L D Blumhardt; T Jaspan
Journal:  Neuroradiology       Date:  2001-08       Impact factor: 2.804

6.  Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a.

Authors:  R A Rudick; E Fisher; J C Lee; J T Duda; J Simon
Journal:  Mult Scler       Date:  2000-12       Impact factor: 6.312

7.  A Wallerian degeneration pattern in patients at risk for MS.

Authors:  J H Simon; R P Kinkel; L Jacobs; L Bub; N Simonian
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

8.  A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.

Authors:  J Pelletier; L Suchet; T Witjas; M Habib; C R Guttmann; G Salamon; O Lyon-Caen; A A Chérif
Journal:  Arch Neurol       Date:  2001-01

9.  Kurtzke scales revisited: the application of psychometric methods to clinical intuition.

Authors:  J Hobart; J Freeman; A Thompson
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

10.  One year follow up study of primary and transitional progressive multiple sclerosis.

Authors:  V L Stevenson; D H Miller; S M Leary; M Rovaris; F Barkhof; B Brochet; V Dousset; M Filippi; R Hintzen; X Montalban; C H Polman; A Rovira; J de Sa; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

View more
  14 in total

1.  Diffusion tensor MRI as a biomarker in axonal and myelin damage.

Authors:  Wint Yan Aung; Soe Mar; Tammie Ls Benzinger
Journal:  Imaging Med       Date:  2013-10-01

2.  Corpus callosum index and long-term disability in multiple sclerosis patients.

Authors:  Ozgür Yaldizli; Ramin Atefy; Achim Gass; Dietrich Sturm; Stephanie Glassl; Barbara Tettenborn; Norman Putzki
Journal:  J Neurol       Date:  2010-03-03       Impact factor: 4.849

3.  Fatigue and progression of corpus callosum atrophy in multiple sclerosis.

Authors:  Özgür Yaldizli; Stephanie Glassl; Dietrich Sturm; Athina Papadopoulou; Achim Gass; Barbara Tettenborn; Norman Putzki
Journal:  J Neurol       Date:  2011-05-19       Impact factor: 4.849

4.  A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI images.

Authors:  Juha Martola; Jakob Bergström; Sten Fredrikson; Leszek Stawiarz; Jan Hillert; Yi Zhang; Olof Flodmark; Anders Lilja; Anders Ekbom; Peter Aspelin; Maria Kristoffersen Wiberg
Journal:  Neuroradiology       Date:  2009-09-23       Impact factor: 2.804

5.  Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.

Authors:  M P Sampat; A M Berger; B C Healy; P Hildenbrand; J Vass; D S Meier; T Chitnis; H L Weiner; R Bakshi; C R G Guttmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-20       Impact factor: 3.825

6.  An animal model of cortical and callosal pathology in multiple sclerosis.

Authors:  Mario Mangiardi; Daniel K Crawford; Xiaoyu Xia; Sienmi Du; Rebecca Simon-Freeman; Rhonda R Voskuhl; Seema K Tiwari-Woodruff
Journal:  Brain Pathol       Date:  2010-11-10       Impact factor: 6.508

7.  Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.

Authors:  Katherine C Gao; Govind Nair; Irene C M Cortese; Alan Koretsky; Daniel S Reich
Journal:  Neuroimage       Date:  2014-06-16       Impact factor: 6.556

8.  Corpus callosum damage and cognitive dysfunction in benign MS.

Authors:  Sarlota Mesaros; Maria A Rocca; Gianna Riccitelli; Elisabetta Pagani; Marco Rovaris; Domenico Caputo; Angelo Ghezzi; Ruggero Capra; Antonio Bertolotto; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2009-08       Impact factor: 5.038

9.  Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.

Authors:  Hagen H Kitzler; Jason Su; Michael Zeineh; Cynthia Harper-Little; Andrew Leung; Marcelo Kremenchutzky; Sean C Deoni; Brian K Rutt
Journal:  Neuroimage       Date:  2011-09-02       Impact factor: 6.556

10.  Corpus callosum microstructural changes correlate with cognitive dysfunction in early stages of relapsing-remitting multiple sclerosis: axial and radial diffusivities approach.

Authors:  Carolina de Medeiros Rimkus; Thiago de Faria Junqueira; Katarina Paz Lyra; Marcel P Jackowski; Melissa A R Machado; Eliane C Miotto; Dagoberto Callegaro; Maria Concepción García Otaduy; Claudia da Costa Leite
Journal:  Mult Scler Int       Date:  2011-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.